Prostate News Archive
28-Jan-2007
Ciphergen Announces Issuance Of European Patent Covering A Method For Aiding Prostate Cancer Diagnosis (Medical News Today)
Ciphergen Biosystems, Inc. (Nasdaq: CIPH) today announced that the European Patient Office (EPO) has issued EU Patent No. 1 224 466, entitled "prostate Cancer Marker Proteins," for aiding in prostate cancer diagnosis. [click link for full article] Ciphergen gets EU patent on prostate cancer diagnosis (bizjournals.com via Yahoo! Finance)
Ciphergen Biosystems Inc. said Thursday the European Patent Office issued the company a patent covering a method for aiding prostate cancer diagnosis. No Link Between Viral Findings In The Prostate And Subsequent Cancer Development (Medical News Today)
UroToday.com- Recently, mutations in genes associated with immune defense and a link to the development of prostate cancer (CaP) has been proposed by several scientific studies. In addition, epidemiologic reports suggest that men with prior history of sexually transmitted infections have an increased relative risk for development of CaP. Based upon these reports Dr. [click link for full article]
Back to Prostate News Archive
